Cargando…
L1 Cell Adhesion Molecule Confers Radioresistance to Ovarian Cancer and Defines a New Cancer Stem Cell Population
Many solid tumors, including ovarian cancer, contain small populations of cancer stem cells (CSCs). These cells are usually resistant against conventional cancer therapies and play a role in disease recurrence. We demonstrated that the L1 cell adhesion molecule (L1CAM) is a new CSC target in ovarian...
Autores principales: | Terraneo, Nastassja, Jacob, Francis, Peitzsch, Claudia, Dubrovska, Anna, Krudewig, Christiane, Huang, Yen-Lin, Heinzelmann-Schwarz, Viola, Schibli, Roger, Béhé, Martin, Grünberg, Jürgen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017143/ https://www.ncbi.nlm.nih.gov/pubmed/31952346 http://dx.doi.org/10.3390/cancers12010217 |
Ejemplares similares
-
Novel Therapeutic Strategies for Ovarian Cancer Stem Cells
por: Terraneo, Nastassja, et al.
Publicado: (2020) -
Combination of lutetium-177 labelled anti-L1CAM antibody chCE7 with the clinically relevant protein kinase inhibitor MK1775: a novel combination against human ovarian carcinoma
por: Lindenblatt, Dennis, et al.
Publicado: (2018) -
Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma
por: Kurth, Ina, et al.
Publicado: (2015) -
Network-based analysis of prostate cancer cell lines reveals novel marker gene candidates associated with radioresistance and patient relapse
por: Seifert, Michael, et al.
Publicado: (2019) -
Cancer Stem Cells and Radioresistance: DNA Repair and Beyond
por: Schulz, Alexander, et al.
Publicado: (2019)